Clinical Trials in New York

Showing 10261-10280 of 22,668 trials

A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma

NCT03877055

The purpose of this study is to test the safety and any good and bad side effects of combining 2 study drugs, copanlisib and ibrutinib. This combination of drugs could shrink your Mantle Cell Lymphoma (MCL), but it could also cause side effects. Both these drugs have been given to people before, but this is the first time that they are being given together.

Mantle Cell Lymphoma (MCL)

Memorial Sloan Kettering Cancer Center8 participantsStarted Mar 2019

Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States • Commack, New York, United States +3 more locations

COMPLETEDPhase 2< 1 mile

Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)

NCT00864227

A bone marrow transplant, which is a type of stem cell transplant, is a treatment option for people with leukemia or lymphoma. Recently, stem cell transplants using umbilical cord blood have become a treatment option for people with these types of cancers. This study will evaluate the effectiveness of a stem cell transplant using umbilical cord blood, along with lower doses of chemotherapy, to treat people with leukemia or lymphoma.

Precursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteBurkitt Lymphoma+3 more

Medical College of Wisconsin54 participantsStarted Dec 2008

Duarte, California, United States • Gainesville, Florida, United States • Tampa, Florida, United States +13 more locations

A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma

Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)

Find Trials by Condition in New York

COVID-19 PrEP HCW HCQ Study

RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF

Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP

Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

RTX-321 Monotherapy in Patients With HPV 16+ Tumors

Naxitamab and GM-CSF in People With Neuroblastoma

Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

Detection of Heart Conditions Using Artificial Intelligence

A Comparison of Nivolumab-based Treatments in a Real-world PD-L1 Positive Metastatic Melanoma Population in the US

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata

Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia

A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)

Ranibizumab and Bevacizumab for Diabetic Macular Edema

A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial